• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Suicidality among users of glucagon-like peptide-1 receptor agonists: An emerging signal?

作者信息

Lau Darren, Gamble John-Michael

机构信息

Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

School of Pharmacy, Faculty of Science, University of Waterloo, Kitchener, Ontario, Canada.

出版信息

Diabetes Obes Metab. 2024 Apr;26(4):1150-1156. doi: 10.1111/dom.15459. Epub 2024 Jan 16.

DOI:10.1111/dom.15459
PMID:38229461
Abstract
摘要

相似文献

1
Suicidality among users of glucagon-like peptide-1 receptor agonists: An emerging signal?胰高血糖素样肽-1受体激动剂使用者中的自杀倾向：一个新出现的信号？
Diabetes Obes Metab. 2024 Apr;26(4):1150-1156. doi: 10.1111/dom.15459. Epub 2024 Jan 16.
2
The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS).胰高血糖素样肽-1受体激动剂（GLP-1 RAs）与自杀倾向之间的关联：向美国食品药品监督管理局不良事件报告系统（FAERS）提交的报告
Expert Opin Drug Saf. 2024 Jan;23(1):47-55. doi: 10.1080/14740338.2023.2295397. Epub 2023 Dec 19.
3
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas.胰高血糖素样肽-1受体激动剂（GLP-1 RAs）与自杀行为：我们了解什么及未来展望
Expert Opin Drug Saf. 2024 May;23(5):539-542. doi: 10.1080/14740338.2024.2335215. Epub 2024 Mar 26.
4
Preliminary Review Finds No Link Between GLP-1 Receptor Agonists and Suicidality.初步审查发现胰高血糖素样肽-1受体激动剂与自杀行为之间无关联。
Am J Nurs. 2024 May 1;124(5):20. doi: 10.1097/01.NAJ.0001016352.54091.a1. Epub 2024 Apr 25.
5
Recent developments in GLP-1RA therapy: A review of the latest evidence of efficacy and safety and differences within the class.胰高血糖素样肽-1受体激动剂疗法的最新进展：疗效与安全性的最新证据及该类别内差异的综述
Diabetes Obes Metab. 2021 Sep;23 Suppl 3:30-39. doi: 10.1111/dom.14487.
6
An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future.每周一次胰高血糖素样肽-1 受体激动剂概述——现有疗效和安全性数据及未来展望。
Diabetes Obes Metab. 2011 May;13(5):394-407. doi: 10.1111/j.1463-1326.2011.01357.x. Epub 2011 Jan 5.
7
Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction.基于肠降血糖素的 2 型糖尿病治疗药物：对疗效、安全性和患者满意度的直接比较的综述。
Int J Clin Pharm. 2013 Apr;35(2):159-72. doi: 10.1007/s11096-012-9729-9. Epub 2012 Dec 22.
8
GLP-1 analogue therapy for obesity in people from Asia.亚洲人群肥胖的胰高血糖素样肽-1类似物疗法。
Lancet Diabetes Endocrinol. 2024 Mar;12(3):153-154. doi: 10.1016/S2213-8587(24)00031-7. Epub 2024 Feb 5.
9
Risk of thyroid cancer associated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: A population-based cohort study.2型糖尿病患者中胰高血糖素样肽-1受体激动剂和二肽基肽酶-4抑制剂与甲状腺癌风险的关系：一项基于人群的队列研究。
Diabetes Obes Metab. 2024 Jan;26(1):108-117. doi: 10.1111/dom.15292. Epub 2023 Sep 21.
10
Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents.胰高血糖素样肽-1 类似物治疗 2 型糖尿病：现有及新兴药物。
Drugs. 2011 Sep 10;71(13):1675-88. doi: 10.2165/11592810-000000000-00000.

引用本文的文献

1
Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons.胰高血糖素样肽-1受体激动剂的获益-风险评估：对皮肤科医生和整形外科医生的启示
Dermatol Ther (Heidelb). 2025 Sep 9. doi: 10.1007/s13555-025-01537-5.
2
The interface of depression and diabetes: treatment considerations.抑郁症与糖尿病的关联：治疗考量
Transl Psychiatry. 2025 Jan 24;15(1):22. doi: 10.1038/s41398-025-03234-5.
3
Antidepressants and Weight Gain: An Update on the Evidence and Clinical Implications.抗抑郁药与体重增加：证据及临床意义的最新进展
Curr Obes Rep. 2025 Jan 3;14(1):2. doi: 10.1007/s13679-024-00598-5.
4
Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study.胰高血糖素样肽-1 受体激动剂与糖尿病和肥胖个体的自杀意念和自残行为的关联：一项基于倾向评分的基于人群的队列研究。
Diabetologia. 2024 Nov;67(11):2471-2480. doi: 10.1007/s00125-024-06243-z. Epub 2024 Aug 6.